Literature DB >> 19833905

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Björn K I Meijers1, Henriette De Loor, Bert Bammens, Kristin Verbeke, Yves Vanrenterghem, Pieter Evenepoel.   

Abstract

BACKGROUND AND OBJECTIVES: Indoxyl sulfate and p-cresyl sulfate are important representatives of the protein-bound uremic retention solutes. Serum levels of p-cresyl sulfate and indoxyl sulfate are linked to cardiovascular outcomes and chronic kidney disease progression, respectively. They share important features such as the albumin-binding site, low dialytic clearance, and both originate from protein fermentation. Whether serum concentrations are related is, however, not known. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In an observational study in 75 maintenance hemodialysis patients, we studied agreement between indoxyl sulfate and p-cresyl sulfate serum concentrations, dialytic reduction rates, and dialytic clearances. Concentrations were determined by HPLC. Dialytic clearances were determined from total spent dialysate collections. In vitro spiking experiments were performed to explore protein binding characteristics.
RESULTS: Indoxyl sulfate and p-cresyl sulfate total serum concentrations were not related (r = 0.02, P = 0.9), whereas free serum concentrations were only moderately related (r = 0.53, P < 0.001). Indoxyl sulfate and p-cresyl sulfate share the same albumin binding site, for which they are competitive binding inhibitors. Intriguingly, indoxyl sulfate and p-cresyl sulfate reduction rates (r = 0.91, P < 0.001) and dialytic clearances (r = 0.97, P < 0.001) correlated tightly.
CONCLUSIONS: Indoxyl sulfate and p-cresyl sulfate serum concentrations are not associated, suggesting different metabolic pathways. Indoxyl sulfate and p-cresyl sulfate are both valid markers to monitor behavior of protein-bound solutes during dialysis. Finally, they are competitive binding inhibitors for the same albumin binding site.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833905      PMCID: PMC2798868          DOI: 10.2215/CJN.02940509

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  31 in total

1.  The characterization of two specific drug binding sites on human serum albumin.

Authors:  G Sudlow; D J Birkett; D N Wade
Journal:  Mol Pharmacol       Date:  1975-11       Impact factor: 4.436

2.  The adsorptive capacity of serum proteins in renal insufficiency.

Authors:  B BREYER; F J RADCLIFF
Journal:  Aust J Exp Biol Med Sci       Date:  1954-06

3.  Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uremic and normal serum.

Authors:  Henriette de Loor; Bert Bammens; Pieter Evenepoel; Vicky De Preter; Kristin Verbeke
Journal:  Clin Chem       Date:  2005-08       Impact factor: 8.327

4.  The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients.

Authors:  T Niwa; T Nomura; S Sugiyama; T Miyazaki; S Tsukushi; S Tsutsui
Journal:  Kidney Int Suppl       Date:  1997-11       Impact factor: 10.545

5.  Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.

Authors:  M Hida; Y Aiba; S Sawamura; N Suzuki; T Satoh; Y Koga
Journal:  Nephron       Date:  1996       Impact factor: 2.847

6.  Determination of indoxyl sulfate in plasma of patients with renal failure by use of ion-pairing liquid chromatography.

Authors:  L A Stanfel; P F Gulyassy; E A Jarrard
Journal:  Clin Chem       Date:  1986-06       Impact factor: 8.327

7.  Characterization of binding site of uremic toxins on human serum albumin.

Authors:  T Sakai; A Takadate; M Otagiri
Journal:  Biol Pharm Bull       Date:  1995-12       Impact factor: 2.233

8.  Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure.

Authors:  T Miyazaki; M Ise; M Hirata; K Endo; Y Ito; H Seo; T Niwa
Journal:  Kidney Int Suppl       Date:  1997-12       Impact factor: 10.545

9.  Removal of P-cresol sulfate by hemodialysis.

Authors:  Andres W Martinez; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

Review 10.  Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure.

Authors:  T Niwa
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

View more
  58 in total

1.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

2.  Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.

Authors:  Johannes Holle; Uwe Querfeld; Marietta Kirchner; Alexandros Anninos; Jürgen Okun; Daniela Thurn-Valsassina; Aysun Bayazit; Ana Niemirska; Nur Canpolat; Ipek Kaplan Bulut; Ali Duzova; Ali Anarat; Rukshana Shroff; Yelda Bilginer; Salim Caliskan; Cengiz Candan; Jerome Harambat; Zeynep Birsin Özcakar; Oguz Soylemezoglu; Sibylle Tschumi; Sandra Habbig; Ebru Yilmaz; Ayse Balat; Aleksandra Zurowska; Nilgun Cakar; Birgitta Kranz; Pelin Ertan; Anette Melk; Karolis Azukaitis; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2019-08-19       Impact factor: 3.714

Review 3.  Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial Fibrillation.

Authors:  Shih-Yu Huang; Yi-Ann Chen; Shih-Ann Chen; Yi-Jen Chen; Yung-Kuo Lin
Journal:  Acta Cardiol Sin       Date:  2016-05       Impact factor: 2.672

Review 4.  Aryl hydrocarbon receptor ligands in cancer: friend and foe.

Authors:  Iain A Murray; Andrew D Patterson; Gary H Perdew
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

5.  p-Cresol and cardiovascular risk in mild-to-moderate kidney disease.

Authors:  Björn K I Meijers; Kathleen Claes; Bert Bammens; Henriette de Loor; Liesbeth Viaene; Kristin Verbeke; Dirk Kuypers; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 8.237

6.  p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease.

Authors:  Cheng-Jui Lin; Han-Hsiang Chen; Chi-Feng Pan; Chih-Kuang Chuang; Tuen-Jen Wang; Fang-Ju Sun; Chih-Jen Wu
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

7.  Kt/Vurea and Nonurea Small Solute Levels in the Hemodialysis Study.

Authors:  Timothy W Meyer; Tammy L Sirich; Kara D Fong; Natalie S Plummer; Tariq Shafi; Seungyoung Hwang; Tanushree Banerjee; Yunnuo Zhu; Neil R Powe; Xin Hai; Thomas H Hostetter
Journal:  J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 10.121

8.  Increased levels of total P-Cresylsulphate and indoxyl sulphate are associated with coronary artery disease in patients with diabetic nephropathy.

Authors:  Cheng-An Chiu; Li-Fen Lu; Teng-Hung Yu; Wei-Chin Hung; Fu-Mei Chung; I-Ting Tsai; Chih-Ying Yang; Chia-Chang Hsu; Yung-Chuan Lu; Chao-Ping Wang; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2011-02-10

9.  Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.

Authors:  Chao-Hung Wang; Mei-Ling Cheng; Min-Hui Liu; Ming-Shi Shiao; Kuang-Hung Hsu; Yu-Yen Huang; Cheng-Cheng Lin; Jui-Fen Lin
Journal:  Heart Vessels       Date:  2015-07-02       Impact factor: 2.037

Review 10.  Colon may provide new therapeutic targets for treatment of chronic kidney disease with Chinese medicine.

Authors:  Chuan Zou; Zhao-Yu Lu; Yu-Chi Wu; Li-Hong Yang; Guo-Bin Su; Xi-Na Jie; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2013-01-31       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.